Oxford spinout developing novel therapeutics based on deep expertise in immune cell regulation.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Osage University Partners and Oxford University Innovation sign MoU on investment into Oxford University spinouts.
Oxford University, Sensyne Health, Evotec, and OSI create new partnership called LAB10x to accelerate data-driven drug discovery powered by AI
LAB10x aims to accelerate the commercialisation of the next generation of digital therapeutics and data-driven drug discovery from clinical artificial intelligence research and digital health innovations at Oxford University
The Oxford University spinout secures investment from Centrica Innovations to support growth.
Development of a vaccine candidate with potential to save millions worldwide will be accelerated in commercialisation deal with Blue Water Vaccines.
The Oxford University spinout plans to use the investment to fuel its structural mass spectrometry to identify new medicines.
The University of Oxford spinout also inks clinical paper in Lancet Psychiatry, appoints CEO and sets up Oxford HQ and London development hub.